Zhang Y, Wang F, Sun HR, Huang YK, et al. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer. J Cancer Res Clin Oncol 2021 Apr 23. pii: 10.1007/s00432-021-03633.
PMID: 33891173